Literature DB >> 758369

Multiple nevoid basal-cell carcinoma syndrome (Gorlin's syndrome): possible confusion with metastatic medulloblastoma. Case report.

J C Hawkins, H J Hoffman, L E Becker.   

Abstract

The authors report a diagnostic dilemma involving a child who, 8 years previously, had total excision of a medulloblastoma. On x-ray studies, lytic lesions of the skull were seen. The differential diagnosis and some of the clinical and pathological aspects of the nevoid basal-cell carcinoma syndrome versus metastases are discussed.

Entities:  

Mesh:

Year:  1979        PMID: 758369     DOI: 10.3171/jns.1979.50.1.0100

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  [Calcification of the falx cerebri. A pathognomonic symptom of Gorlin-Goltz syndrome].

Authors:  J T Lambrecht; S Stübinger; B Siewert; F Härle
Journal:  HNO       Date:  2005-08       Impact factor: 1.284

2.  Widespread osteolytic lesions of the long bones in basal cell nevus syndrome.

Authors:  G Blinder; Y Barki; M Pezt; J Bar-Ziv
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

Review 3.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

4.  Cultured diploid fibroblasts from patients with the nevoid basal cell carcinoma syndrome are hypersensitive to killing by ionizing radiation.

Authors:  G L Chan; J B Little
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

5.  The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma.

Authors:  R Cowan; P Hoban; A Kelsey; J M Birch; R Gattamaneni; D G Evans
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.